04.09.2007
HealthShares Announces Change to the HealthShares™ Ophthalmology Index
New York (April 9, 2007) – HealthShares™ Inc., an investment company with a series
of 20 underlying fund portfolios, today announced it has been informed by Standard &
Poor’s, the calculating agent for the HealthShares™ Ophthalmology Index, that effective
at the opening of trading on Thursday April 12, 2007, Watson Pharmaceuticals Inc.
(NYSE:WPI) will replace Biogen Idec Inc. (Nasdaq: BIIB) in the HealthShares™
Ophthalmology Index. Companies included in the Ophthalmology Index are engaged in
the research, clinical development and/or commercialization of therapeutic agents by
means of pharmaceuticals, medical devices or biomaterials for the treatment of various
diseases of the eye.
HealthShares Announces Change to the HealthShares™ Ophthalmology Index
<< back to news